Whilst our demonstration of functional behavior of KEEs here is limited mainly to MLL-AF4 leukemia cells, the fact that a similar proportion of enhancers are marked with H3K79me2 in other cell types suggests that a role for this modification in enhancer function may be more generally applicable. Here, KMT2A is linked to leukemia.